300753 爱朋医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.2771.198-10.3697.11813.710
总资产报酬率 ROA (%)1.0490.957-8.5876.26412.235
投入资产回报率 ROIC (%)1.1231.051-9.4206.89113.671

边际利润分析
销售毛利率 (%)68.19365.54849.42763.93657.436
营业利润率 (%)8.5623.308-27.27712.09625.624
息税前利润/营业总收入 (%)7.7933.466-27.87411.47423.644
净利润/营业总收入 (%)4.9022.002-23.50711.56121.863

收益指标分析
经营活动净收益/利润总额(%)25.56247.56295.03189.31586.634
价值变动净收益/利润总额(%)-4.027-10.417-1.5741.5501.118
营业外收支净额/利润总额(%)-15.638-1.1422.630-0.881-1.448

偿债能力分析
流动比率 (X)4.0793.4063.0276.3256.139
速动比率 (X)3.4252.9772.6125.4445.767
资产负债率 (%)16.51018.89021.12913.1850.106
带息债务/全部投入资本 (%)8.3207.6058.1750.5460.186
股东权益/带息债务 (%)1,053.3641,160.6661,066.01517,278.57953,465.284
股东权益/负债合计 (%)504.989428.757372.836657.697846.140
利息保障倍数 (X)20.05317.728-199.659-22.232-14.648

营运能力分析
应收账款周转天数 (天)143.457110.530128.81078.10052.805
存货周转天数 (天)196.966144.458141.201107.29956.880